Targeting Injury Pathways to Counteract Pulmonary Agent and Vesicant Toxicity
Targeting Injury Pathways to Counteract Pulmonary Agent and Vesicant Toxicity
批准号:
8922001
负责人:
SVEN-ERIC JORDT
金额:
$58.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-29 至 2018-05-31
关键词:
AccidentsAcroleinAfferent NeuronsBullaCalciumCalcium SignalingCardiovascular systemCell DeathChemical ExposureChemical IndustryChemical InjuryChemical Warfare AgentsChemicalsChlorineChronicChronic Obstructive Airway DiseaseCorrosivesCutaneousDataDisinfectionDrug FormulationsEdemaEnvironmental and Occupational ExposureEpithelialEpitheliumFormulationGasesGenesGoalsHumanInflammationInflammatoryInflammatory ResponseInjection of therapeutic agentInjuryIntramuscularIon ChannelIsocyanatesLaboratoriesLeukocytesLinkLungLung InflammationMAPK14 geneMediatingMediator of activation proteinMental DepressionMusMustard GasMutationNeuronsNeuropeptidesOxidantsOzonePainPathway interactionsPharmaceutical PreparationsPhosgenePhosphotransferasesPlayPreparationPrincipal InvestigatorPulmonary EdemaReagentReflex actionResearchResearch InstituteRiotsRiskRoleSignal PathwaySignal TransductionSkinSkin injurySpecialistSurvival RateTRP channelTerrorismTissuesToxic effectTransducersVariantVesicantsWorkafferent nerveairway epitheliumairway hyperresponsivenessanalogbasechlorine gasefficacy testingimprovedinjuredirritationkeratinocytelung injurymitogen-activated protein kinase p38novelpublic health relevancepulmonary agentsreceptorresponse to injury
中文摘要
描述(由申请人提供):氯(CI2),光气,发泡剂和亲电活性化学品(工业和防暴剂)被认为是最紧迫的化学威胁,被转移到恐怖袭击中,或在事故中释放。在过去的四年里,Jordt实验室的研究已经确定了TRPA1,一种在感觉神经元中表达的瞬时受体电位离子通道,是氯、防暴剂和工业化学品(如丙烯醛和异氰酸酯)的主要神经元靶点。使用TRPA1拮抗剂对氯暴露小鼠进行暴露后处理,可显著降低肺部炎症和损伤参数。同样的TRPA1拮抗剂增加了光气暴露小鼠的存活率,也抑制了硫芥类似物CEES引起的水肿损伤。在我们最近的工作中,我们确定了TRPV4,一种在肺上皮和脉管系统中表达的离子通道,作为氧化诱导肺损伤的额外介质。TRPV4的激活可导致严重的肺损伤和心血管抑制,我们发现TRPV4拮抗剂可抑制臭氧诱导的氧化性肺水肿。TRPV3是角质形成细胞中的一个TRP离子通道,是发泡剂和腐蚀性亲电试剂引起皮肤损伤的候选介质。TRP通道通过钙的流入激活p38 MAP激酶,p38 MAP激酶是损伤组织中炎症和细胞死亡的主要传感器和激活剂。总之,我们假设TRP通道是化学战剂的主要目标,通过神经元和局部细胞信号传导介导局部和全身损伤和炎症。在这个提议中,我们的目标是:1:开发先进的肌内TRPA1拮抗剂,用于立即和持续释放,以抵消氯和泡剂损伤;2:检查肺和皮肤TRP离子通道在化学损伤中的作用;3:研究p38激酶拮抗剂在肺和皮肤化学损伤中的作用。
英文摘要
DESCRIPTION (provided by applicant): Chlorine (CI2), phosgene, vesicants and electrophilic reactive chemicals (industrial and riot control agents) are considered among the most imminent chemical threats to be diverted for terrorism attacks, or released during accidents. In the last four years research in the Jordt laboratory has identified TRPA1, a Transient Receptor Potential ion channel expressed in sensory neurons, as the major neuronal target of chlorine, riot control agents and Industrial chemicals such as acrolein and isocyanates. Post-exposure treatment of chlorine-exposed mice with a TRPA1 antagonist strongly reduced lung inflammation and injury parameters. The same TRPA1 antagonist increased survival rates of phosgene-exposed mice, and also inhibited vesicant injury induced by the sulfur mustard analog, CEES. In our recent work we identified TRPV4, an ion channel expressed in the lung epithelium and vasculature, as an additional mediator of oxidant-induced pulmonary injury. Activation of TRPV4 leads to severe lung injury and cardiovascular depression, and we show that a TRPV4 antagonist inhibits ozone induced oxidative lung edema. TRPV3, a TRP ion channel in keratinocytes, is a candidate mediator of cutaneous injury by vesicants and corrosive electrophiles. TRP channel, through influx of calcium, activate p38 MAP kinase, a major transducer and activator of inflammation and cell death in injured tissue. In summary, we hypothesize that TRP channels are major targets of chemical warfare agents, mediating local and systemic injury and inflammation through neuronal and local cellular signaling. In this proposal we aim to 1: Develop advanced intramuscular formulations of TRPA1 antagonists for immediate and sustained release to counteract chlorine and vesicant injury, 2: Examine the role of pulmonary and cutaneous TRP ion channels in chemical injury, and 3: Investigate the effects of a p38 kinase antagonist in pulmonary and cutaneous chemical injury.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.taap.2017.03.007
发表时间:
2017-06-01
期刊:
Toxicology and applied pharmacology
影响因子:
3.8
作者:
[Achanta S, Jordt SE]
通讯作者:
Jordt SE
DOI:
10.1016/j.toxlet.2018.03.007
发表时间:
2018-09-01
期刊:
Toxicology letters
影响因子:
3.5
作者:
[Achanta S, Chintagari NR, Brackmann M, Balakrishna S, Jordt SE]
通讯作者:
Jordt SE
DOI:
10.1084/jem.20202507
发表时间:
2021-04-05
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Jordt SE]
通讯作者:
Jordt SE
Involvement of Transient Receptor Potential Cation Channel Member A1 activation in the irritation and pain response elicited by skin-lightening reagent hydroquinone.
瞬态受体电位阳离子通道成员 A1 激活参与亮肤试剂氢醌引起的刺激和疼痛反应
DOI:
10.1038/s41598-017-07651-5
发表时间:
2017-08-08
期刊:
Scientific reports
影响因子:
4.6
作者:
[Tai Y, Wang C, Wang Z, Liang Y, Du J, He D, Fan X, Jordt SE, Liu B]
通讯作者:
Liu B
Nicotine Pouches: Chemical Composition, Toxicity and Behavioral Effects of a New Tobacco Product Category
-
批准号:10673370
-
项目类别:
-
资助金额:$41.65万
-
财政年份:2022
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Molecular Core
-
批准号:9703532
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2020
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Anesthetic and synthetic cooling flavors in E-cigarettes: Chemistry and respiratory effects modulating nicotine intake
-
批准号:9982329
-
项目类别:
-
资助金额:$47.35万
-
财政年份:2018
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Mechanisms of Itch in Poison Ivy-Induced Allergic Contact Dermatitis
-
批准号:9164682
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2016
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
-
批准号:8900466
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2012
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
-
批准号:8416589
-
项目类别:
-
资助金额:$40.43万
-
财政年份:2012
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
-
批准号:8547809
-
项目类别:
-
资助金额:$16.09万
-
财政年份:2012
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Counterirritation by Menthol: Molecular Targets and Role in Airway Disease
-
批准号:8022797
-
项目类别:
-
资助金额:$44.64万
-
财政年份:2011
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
-
批准号:8209236
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2011
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
-
批准号:8605272
-
项目类别:
-
资助金额:$36.29万
-
财政年份:2011
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Counter-irritation by Menthol: Molecular Targets and Role in Airway Disease
-
批准号:8431661
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2011
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
-
批准号:8580913
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2011
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
-
批准号:8402151
-
项目类别:
-
资助金额:$7.44万
-
财政年份:2011
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Sensory Neural Mechanisms of Pulmonary Agent and Vesicant Toxicity
-
批准号:7447445
-
项目类别:
-
资助金额:$45.77万
-
财政年份:2006
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Targeting Injury Pathways to Counteract Pulmonary Agent and Vesicant Toxicity
-
批准号:8547256
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2006
-
负责人:SVEN-ERIC JORDT
-
依托单位:
TRPA1 Channels in Sensory Neurons as Targets for Environmental Irritants
-
批准号:8300949
-
项目类别:
-
资助金额:$9.43万
-
财政年份:2006
-
负责人:SVEN-ERIC JORDT
-
依托单位:
TRPA1 Channels in Sensory Neurons as Targets for Environmental Irritants
-
批准号:7898523
-
项目类别:
-
资助金额:$39.66万
-
财政年份:2006
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Sensory Neural Mechanisms of Pulmonary Agent and Vesicant Toxicity
-
批准号:7858028
-
项目类别:
-
资助金额:$48.08万
-
财政年份:2006
-
负责人:SVEN-ERIC JORDT
-
依托单位:
TRPA1 Channels in Sensory Neurons as Targets for Environmental Irritants
-
批准号:7685299
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2006
-
负责人:SVEN-ERIC JORDT
-
依托单位:
Sensory Neural Mechanisms of Pulmonary Agent and Vesicant Toxicity
-
批准号:7663892
-
项目类别:
-
资助金额:$47.15万
-
财政年份:2006
-
负责人:SVEN-ERIC JORDT
-
依托单位:
国内基金
海外基金
Acrolein调控耳蜗核神经元-胶质细胞网络参与感音神经性耳聋发病机制的研究
-
批准号:81570922
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2015
-
负责人:屈涓
-
依托单位:
acrolein在脊髓损伤后慢性疼痛发生发展中的作用及机制研究
-
批准号:81171052
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:武胜昔
-
依托单位: